Navigation Links
National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
Date:10/11/2007

Program Receives 2007 Distinctively Blue Award for Hospital Quality Improvement

BALTIMORE, Oct. 11 /PRNewswire-USNewswire/ -- Successful efforts to reduce hospital-acquired infections in the mid-Atlantic region were recently honored with a national award from the BlueCross BlueShield Association of America. CareFirst BlueCross BlueShield (CareFirst) received the 2007 Distinctively Blue Award for Innovations for the 100,000 Lives and Beyond Collaborative. CareFirst and the Delmarva Foundation for Medical Care, a healthcare quality improvement organization, work jointly on this ongoing program to improve the quality of care in local hospitals.

CareFirst and Delmarva Foundation are working together to build on national patient safety focus areas, including the Institute for Healthcare Improvement (IHI) 100,000 Lives and 5 Million Lives campaigns.

"Delmarva Foundation is an outstanding partner with us on a number of fronts," said Dr. Jon Shematek, CareFirst Senior Vice President and Chief Medical Officer. "We are making measurable strides in improving health care quality and this award confirms the progress we are seeing."

The 100,000 Lives and Beyond Collaborative, a program offered by Delmarva Foundation with financial support from CareFirst, ran from January 2006 to January 2007. Delmarva worked with 28 hospitals from Maryland, the District of Columbia, and northern Virginia to implement evidence-based strategies to improve the process of care and clinical outcomes in the intensive care unit (ICU) and operating room (OR). The 100,000 Lives and Beyond Collaborative aligned national and regional regulatory and accreditation patient safety goals and priorities with clinically relevant outcomes and local priorities.

Highlighted results from the 100,000 Lives and Beyond Collaborative include:

-- 53% of reporting ICU teams improved compliance with key processes that

can reduce ventilator-associated pneumonia cases; 67% of teams reduced

rates of these infections to zero.

-- 80% of OR teams improved the timing of antibiotics before surgery,

which can reduce rates of surgical infections. In addition, 80% of

teams reported no surgical infections at the end of the

collaborative.

We are so proud of the accomplishments of the hospitals involved in the 100,000 Lives and Beyond Collaborative," commented Dr. Margaret Toth, Delmarva's Chief Quality Officer. "Delmarva and CareFirst are natural partners that continue to be innovative leaders with work on healthcare-associated infections. We look forward to continuing our efforts to improve the quality of healthcare in these important settings."

The Distinctively Blue Award program recognizes quality programs deployed by BlueCross BlueShield-affiliated plans. Of 61 submissions, 6 awards and 2 honorable mentions were given at the BlueCross BlueShield Distinctively Blue Conference.

For more information regarding Delmarva Foundation and quality improvement collaboratives, contact: Bonnie Noble at nobleb@dfmc.org

Delmarva Foundation is a national, not-for-profit organization dedicated to improving healthcare quality in over 30 states. Since 1973, Delmarva has assisted in enhancing care in hospitals, nursing homes, home health agencies, medical practices and health plans. Delmarva conducts work ranging from quality improvement, quality assurance, utilization review to external quality review. The company's corporate headquarters are located in Easton, Maryland with other offices in Baltimore, Maryland; Washington, DC; and Tampa and Tallahassee, Florida. For more information, please visit Delmarva Foundation on the web at http://www.delmarvafoundation.org.


'/>"/>
SOURCE Delmarva Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Key step forward on International Health Rules
6. ICMR along with other International Research organisation with drug development for Neglected Diseases
7. International Osteoporosis Research Centre To Be Started In India.
8. Hepatitis B Vaccine To Be Included In National Immunization Programme
9. Indian hospitals require International Accreditation
10. International Conference On Malaria - Laveran To Genomics
11. UK Govt Says On Course For National Chlamydia Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... WI (PRWEB) , ... March 27, 2017 , ... ... new patients for custom smile makeovers without requiring a referral. Trimble ... orthodontics, gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, ...
(Date:3/27/2017)... ... 2017 , ... This is the second major release since ... 2014. It is the culmination of collaborative efforts by members of the OSEHRA ... Member Zato Health co-funded the ONC certification and provided key technical support throughout ...
(Date:3/27/2017)... MA (PRWEB) , ... March 27, 2017 , ... ... Group, the organization behind the New England Journal of Medicine and NEJM Journal ... NEJM Knowledge+ Pediatrics Board Review was created by a panel of pediatricians from ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may ... of groin injury, it occurs when the muscles around the pelvis become inflamed. ... around the lower torso, as well as accompanying tenderness and weakness. Without proper ...
(Date:3/27/2017)... Atlanta, Georgia (PRWEB) , ... March 27, 2017 ... ... pleased to announce that for a second year in a row; they are ... leading healthcare designers in the industry voted on the award at Design Connections ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES ... FRA: 8IS) Invictus MD is pleased to announce it ... for trading on the TSX Venture Exchange.  ... follows a year of significant achievements for Invictus-MD. Some ... test crops at AB Laboratories Inc. ("AB Labs"), a ...
(Date:3/27/2017)... -- The global clinical chemistry analyzers ... 2025, according to a new study by Grand View ... anticipated to be responsible for the high urgency to ... for growth during the forecast period. In addition, growing ... susceptible to chronic diseases, is presumed to impel the ...
(Date:3/27/2017)...  Twist Bioscience, a company accelerating science and innovation ... raised an additional $33 million. To date, Twist Bioscience ... "It is an exciting time to be leading ... to deliver industry-leading gene volume to our customers, enabling ... Leproust, Ph.D., CEO of Twist Bioscience. "We welcome the ...
Breaking Medicine Technology: